TABLE 3.
Univariate and multivariate Cox proportional hazard analysis of clinicopathologic and treatment factors associated with local relapse after BCS for DCIS (n = 1216)
Variable | 5 year LRR rate (%) | Univariate P | Hazard ratio | 95 % Confidence interval | Multivariate P |
---|---|---|---|---|---|
Age | |||||
≥40 years | 3.2 | 0.005 | 1.00 (reference) | ||
<40 years | 10.1 | 2.70 | 1.06–6.93 | 0.038 | |
Initial presentationa | |||||
Clinical | 5.6 | 0.026 | 1.00 (reference) | ||
Radiological | 3.2 | 0.58 | 0.28–1.24 | 0.160 | |
Pathological sizeb | |||||
<1.5 cm | 2.2 | 0.018 | 1.00 (reference) | ||
≥1.5 cm | 5.6 | 2.72 | 1.23–6.01 | 0.013 | |
Margin statusc | |||||
Negative | 3.7 | 0.270 | 1.00 (reference) | ||
Close/positived | 2.2 | 0.51 | 0.21–1.23 | 0.134 | |
ER statuse | |||||
Positive | 2.6 | 0.078 | 1.00 (reference) | ||
Negative | 5.3 | 2.23 | 0.71–7.04 | 0.171 | |
Gradef | |||||
I | 2.2 | 0.340 | 1.00 (reference) | ||
II/III | 3.7 | 1.80 | 0.54–6.03 | 0.340 | |
Radiotherapy | 1.00 (reference) | ||||
Yes | 2.3 | 0.018 | |||
No | 7.9 | 2.68 | 1.36–5.26 | 0.004 | |
Endocrine use | |||||
Yes | 2.0 | 0.087 | 1.00 (reference) | ||
No | 4.6 | 1.29 | 0.62–2.68 | 0.490 |
BCS breast-conserving surgery, DCIS ductal carcinoma-in-situ, LRR locoregional recurrence, ER estrogen receptor
Initial presentation signs were not available for 7 patients
Largest pathological sizes were recorded in 900 patients
Margins were not available for 12 patients
Positive in 4 patients; close (<2 mm) in 99 patients
ER status was determined in 743 patients
Grade was not recorded in 29 patients